Vol 6 Issue 6

CELL AND GENE THERAPY INSIGHTS

July 2020 Issue

Vol 6 Issue 6

Download PDF

Featuring

Issue Spotlight: Immuno-oncology: manufacturing and commercial business models for the new decade
Other articles
Webinars

SPOTLIGHT

Immuno-oncology: manufacturing and commercial business models for the new decade
Usman Azam
Guest Editor:
Usman Azam, President & CEO at Tmunity Therapeutics Inc

Foreword

Immuno-oncology: manufacturing and commercial business models for the new decade – Foreword

Immuno-oncology: manufacturing and commercial business models for the new decade – Foreword

Usman Azam
28 July 2020
Read

Expert Insight

Current and future directions for tumor infiltrating lymphocyte therapy for the treatment of solid tumors

Current and future directions for tumor infiltrating lymphocyte therapy for the treatment of solid tumors

M Fardis, K DiTrapani, F Graf Finckenstein et al.
3 July 2020
Read
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade

Immuno-oncology cell therapies: commercial considerations and strategies for the new decade

Glen Firestone
30 June 2020
Read
Innovating CAR T cell therapy for today and tomorrow

Innovating CAR T cell therapy for today and tomorrow

David Chang
30 June 2020
Read
Decentralized manufacturing: from stem cell transplants to the next generation of cellular immunotherapies

Decentralized manufacturing: from stem cell transplants to the next generation of cellular immunotherapies

Matthew Li, Sadik Kassim
18 June 2020
Read
Commercialization of TCR T-cell therapy: patient journey implications

Commercialization of TCR T-cell therapy: patient journey implications

Kimberly Freeman
17 June 2020
Read

Innovator Insight

Simplifying GMP CART and CAR NK cell therapy manufacturing processes

Simplifying GMP CART and CAR NK cell therapy manufacturing processes

S Dluczek, K Fynes, S Fricke et al.
15 July 2020
Read

Expert Roundtable Video

Expert Roundtable: evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting

Expert Roundtable: evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting

D Adams, G Russotti, E Fearnot et al.
16 July 2020
Watch

Expert Roundtable

Evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting

Evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting

D Adams, G Russotti, E Fearnot et al.
15 July 2020
Read

Interview

Looking to the future of stem cell-derived immunotherapy

Looking to the future of stem cell-derived immunotherapy

Peter Zandstra
17 June 2020
Read
Understanding the drivers of success and failure in CAR T cell therapy

Understanding the drivers of success and failure in CAR T cell therapy

Jan Melenhorst
16 June 2020
Read

Journal articles

Commentary

Clinical trials in the era of Covid-19: successes, failures & ongoing challenges

Clinical trials in the era of Covid-19: successes, failures & ongoing challenges

Sven Kili
4 August 2020
Read

Interview

Innovation in clinical translation of advanced therapies

Innovation in clinical translation of advanced therapies

Mohamed Abou El-Enein
7 August 2020
Read

Commercial Insights

Cell & Gene Therapy Commercial Insight - May 2020

Cell & Gene Therapy Commercial Insight - May 2020

Mark Curtis, Richard Philipson
24 June 2020
Read

Preliminary Communication

A proposed protocol of derived mesenchymal stem cells for the treatment of COVID-19 patients

A proposed protocol of derived mesenchymal stem cells for the treatment of COVID-19 patients

Vasiliki Kalodimou, Alma Reyes-Calavera
10 July 2020
Read

Webinars